Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products
The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.
As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.
You will learn:
What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?
- What are the main points you need to consider when going into the upgrade procedure?
- What do you need to know about EAEU GMP certification?
- What are the readability user testing requirements?
- Timelines
Preparing for a marketing authorization upgrade?
Create a successful submission strategy development. Explore your options in an informal chat.
Who Should Attend?
Professionals from the following fields:
- Regulatory Managers
- Regulatory Strategy Managers
- RA Partnerships Operations Manager
- QA Managers supporting RA
- RA Healthcare Compliance Managers
Duration: 45 min.
Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.
Nargiz Asgarova
Regulatory Affairs Project Manager CIS
Other content that might interest you:
Marketing Authorization Process in Russia
Cultural and language problems are a frequent stumbling block for multinational corporations seeking to register drugs in Russia. Additionally, the Marketing Authorization process in Russia is highly complex, and the paperwork frequently changes as the regulatory...
Drug Registration in Russia
Overview of drug registration in Russia The Russian pharmaceutical industry is expected to exceed two trillion Russian rubles in 2020, representing a roughly 10% growth over the previous year. Pharmaceutical revenues are expected to reach 2.35 trillion Russian rubles...
Preparing for the Affiliate-Based Outsourcing for Regulatory Affairs
Affiliate-Based Outsourcing (ABO) model for regulatory affairs works as a replacement or an extension of the company's internal local regulatory resources, which often do not fully fulfil the needs for the effective organization, flexible resources, business...
